Biogen Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: BIIB
Share price (5/22/26): $193.76
Market cap (5/22/26): $28.6 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from SCHEDULE 13D 13 pages Tender and Support Agreement

from 8-K 123 pages Agreement and Plan of Merger by and Among Apellis Pharmaceuticals, Inc., Aspen Purchaser Sub, Inc. and Biogen Inc. Dated as of March 31, 2026

from 8-K 87 pages Agreement and Plan of Merger by and Among Reata Pharmaceuticals, Inc., Biogen Inc. and River Acquisition, Inc. Dated as of July 28, 2023

from 8-K 83 pages Separation Agreement by and Between Biogen Inc. and Bioverativ Inc. Dated as of January 31, 2017

from 8-K/A 98 pages Asset Purchase Agreement by and Among Elan Pharma International Limited, Elan Pharmaceuticals, Inc. and Biogen Idec International Holding Ltd. Dated as of February 5, 2013

from 8-K ~50 pages Agreement and Plan of Merger by and Among Idec Pharmaceuticals Corporation, Bridges Merger Corporation and Biogen, Inc. Dated as of June 20, 2003

from 8-A12B ~50 pages Rights Agreement

from 8-B12G ~10 pages Agreement and Plan of Merger